NIT
VKTX icon

NumerixS Investment Technologies’s Viking Therapeutics VKTX Stock Holding History

NumerixS Investment Technologies’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-19,100
Closed -$145K – 1349
2018
Q4 		$145K Sell
19,100
-7,405
-28% -$88.5K 0.05% 441
2018
Q3 		$473K Buy
+26,505
New +$315K 0.09% 317

Other funds holding VKTX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NumerixS Investment Technologies's VKTX Position: Q1 2019 in Review

NumerixS Investment Technologies sold out of Viking Therapeutics (VKTX) in Q1 2019, closing a stake of 19,100 shares — an estimated $145K sold.

NumerixS Investment Technologies first reported a position in VKTX in Q3 2018 and held it in 2 quarters. The position peaked at $473K in Q3 2018. 164 funds tracked by Wall St. Rank hold VKTX as of Q1 2019.

  • NumerixS Investment Technologies reported no remaining Viking Therapeutics position as of Q1 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 19,100 Viking Therapeutics shares in Q1 2019, an estimated $145K.
  • NumerixS Investment Technologies first reported a position in Viking Therapeutics in Q3 2018 and held it in 2 quarters.
  • NumerixS Investment Technologies's Viking Therapeutics position peaked at $473K in Q3 2018.
  • 164 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2019.

Based on NumerixS Investment Technologies's 13F filing for Q1 2019, filed 10 May 2019.